Mostrar registro simples

dc.contributor.authorCordioli, Aristides Volpatopt_BR
dc.date.accessioned2010-04-16T09:09:59Zpt_BR
dc.date.issued2001pt_BR
dc.identifier.issn1516-4446pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/19429pt_BR
dc.description.abstractSelective serotonin reuptake inhibitors (SSRIs), clomipramine, and behavior therapy are the first line treatments for obsessive-compulsive (OCD) symptoms. One of the main reasons for treatment non-compliance and early discontinuation of medications by patients or premature change in prescriptions by clinicians are their side effects. Nausea, headache, insomnia, restlessness, sexual dysfunction, and tremors are common with SSRIs; hypotension, dry mouth, constipation, urinary retention, blurred vision, weight gain, sedation and cardiocirculatory problems, with clomipramine. The strategies and guidelines for these drugs’ side effects management are here reviewed, based mainly in case reports and clinical experience. The clinician should be aware of the importance of addressing this issue, educating patients about the most frequent adverse reactions, and how to deal with them in order to prevent unwanted medication discontinuation, and enhance compliance with the treatment.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoporpt_BR
dc.relation.ispartofRevista brasileira de psiquiatria (1999). São Paulo. Vol. 23, supl. 2 (2001), p. 58-61pt_BR
dc.rightsOpen Accessen
dc.subjectInibidores seletivos de recaptação de serotoninapt_BR
dc.subjectObsessive-compulsive disorderen
dc.subjectTreatmenten
dc.subjectClomipraminapt_BR
dc.subjectSelective serotonin reuptake inhibitorsen
dc.subjectTranstorno obsessivo-compulsivopt_BR
dc.subjectClomipramineen
dc.subjectAdverse effectsen
dc.subjectManagementen
dc.titlePrincipais efeitos colaterais das drogas antiobsessivas e seu manejopt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000302866pt_BR
dc.type.originNacionalpt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples